{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:44:50Z","timestamp":1790930690164,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.conb.2011.08.002","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T21:10:26Z","timestamp":1315602626000},"page":"920-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease"],"prefix":"10.1016","volume":"21","author":[{"given":"C Dirk","family":"Keene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiron","family":"Cudaback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen S","family":"Montine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Montine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2011.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.conb.2011.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.conb.2011.08.002_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2377-10-90","article-title":"Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study","volume":"10","author":"Han","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.conb.2011.08.002_bib0020","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","article-title":"Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site","volume":"257","author":"Weisgraber","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2011.08.002_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ygeno.2007.02.002","article-title":"Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease\/marker association","volume":"89","author":"Yu","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.conb.2011.08.002_bib0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1006\/nbdi.2001.0441","article-title":"Apolipoprotein C-I expression in the brain in Alzheimer's disease","volume":"8","author":"Petit-Turcotte","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2011.08.002_bib0035_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2011.08.002_bib0040","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.conb.2011.08.002_bib0045","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.conb.2011.08.002_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","article-title":"Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease","volume":"9","author":"Fagan","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2011.08.002_bib0055_1","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0b013e3181ffe4d1","article-title":"Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects","volume":"75","author":"Chiang","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2011.08.002_bib0065_1","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.conb.2011.08.002_bib0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","article-title":"Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele","volume":"56","author":"Sunderland","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.conb.2011.08.002_bib0075_1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2011.08.002_bib0080","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1523\/JNEUROSCI.1042-08.2008","article-title":"Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice","volume":"28","author":"Xu","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/JMN:23:3:235","article-title":"ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function","volume":"23","author":"Manelli","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/mi.2.6.363","article-title":"Apolipoprotein E, amyloid, and Alzheimer disease","volume":"2","author":"Bales","year":"2002","journal-title":"Mol Interv"},{"key":"10.1016\/j.conb.2011.08.002_bib0095","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2011.08.002_bib0100","doi-asserted-by":"crossref","first-page":"e14586","DOI":"10.1371\/journal.pone.0014586","article-title":"Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-beta in human Alzheimer brain","volume":"6","author":"Jones","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.conb.2011.08.002_bib0105_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2565","article-title":"Regulation of innate immune responses in the brain","volume":"9","author":"Rivest","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance","volume":"30","author":"Sjoberg","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0115","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0120","first-page":"903","article-title":"Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites","volume":"16","author":"Brouwers","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.conb.2011.08.002_bib0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","article-title":"Up-regulated production and activation of the complement system in Alzheimer's disease brain","volume":"154","author":"Yasojima","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.conb.2011.08.002_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.wad.0000165506.60370.94","article-title":"Complement activation in very early Alzheimer disease","volume":"19","author":"Zanjani","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.conb.2011.08.002_bib0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1996.0043","article-title":"Localization and cell association of C1q in Alzheimer's disease brain","volume":"138","author":"Afagh","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.conb.2011.08.002_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-5-9","article-title":"Plaque complement activation and cognitive loss in Alzheimer's disease","volume":"5","author":"Loeffler","year":"2008","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.conb.2011.08.002_bib0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","article-title":"Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease","volume":"18","author":"Webster","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2011.08.002_bib0150","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.152.10.5050","article-title":"beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain","volume":"152","author":"Jiang","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0155","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0160","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.conb.2011.08.002_bib0165","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4049\/jimmunol.0903382","article-title":"IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice","volume":"184","author":"Chakrabarty","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0170","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1523\/JNEUROSCI.1146-08.2008","article-title":"Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease","volume":"28","author":"Richard","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","article-title":"Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease","volume":"113","author":"Ager","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2011.08.002_bib0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.conb.2011.08.002_bib0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/glia.21125","article-title":"Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activation","volume":"59","author":"Li","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.conb.2011.08.002_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-6-16","article-title":"Hippocampal expression of murine TNFalpha results in attenuation of amyloid deposition in vivo","volume":"6","author":"Chakrabarty","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.conb.2011.08.002_bib0195","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1073\/pnas.1006496107","article-title":"Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2","volume":"107","author":"Sloane","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.conb.2011.08.002_bib0200","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni.1775","article-title":"Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE","volume":"10","author":"Farez","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2353\/ajpath.2007.060821","article-title":"Acute brain injury triggers MyD88-dependent, TLR2\/4-independent inflammatory responses","volume":"171","author":"Koedel","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.conb.2011.08.002_bib0210","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1523\/JNEUROSCI.4937-05.2006","article-title":"Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation","volume":"26","author":"Babcock","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0215","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/STROKEAHA.109.572552","article-title":"Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia","volume":"41","author":"Abe","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.conb.2011.08.002_bib0220","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","article-title":"Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease","volume":"181","author":"Jana","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0225_1","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation","volume":"29","author":"Reed-Geaghan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-5-23","article-title":"Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease","volume":"5","author":"Jin","year":"2008","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.conb.2011.08.002_bib0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-6-5","article-title":"MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease","volume":"6","author":"Michaud","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.conb.2011.08.002_bib0245","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1523\/JNEUROSCI.5715-08.2009","article-title":"Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology","volume":"29","author":"Scholtzova","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0250","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2353\/ajpath.2009.090418","article-title":"Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease","volume":"175","author":"Doi","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.conb.2011.08.002_bib0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-4-2","article-title":"Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein","volume":"4","author":"Jin","year":"2007","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.conb.2011.08.002_bib0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.conb.2011.08.002_bib0265","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbi.2010.04.004","article-title":"Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha\/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration","volume":"24","author":"Field","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.conb.2011.08.002_bib0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1096\/fj.03-0364fje","article-title":"The LPS receptor (CD14) links innate immunity with Alzheimer's disease","volume":"18","author":"Fassbender","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.conb.2011.08.002_bib0275","doi-asserted-by":"crossref","first-page":"15369","DOI":"10.1523\/JNEUROSCI.2637-10.2010","article-title":"Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu","volume":"30","author":"Reed-Geaghan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2005.08.047","article-title":"Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease","volume":"391","author":"Minoretti","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2011.08.002_bib0285","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Kariko","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2011.08.002_bib0290","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004010050923","article-title":"RNA sequestration to pathological lesions of neurodegenerative diseases","volume":"96","author":"Ginsberg","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2011.08.002_bib0295","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","article-title":"Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.conb.2011.08.002_bib0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11763-M","article-title":"ApoE immunoreactivity and microglial cells in Alzheimer's disease brain","volume":"195","author":"Uchihara","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2011.08.002_bib0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2005-7104","article-title":"Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia","volume":"7","author":"Chen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.conb.2011.08.002_bib0310","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","article-title":"Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis","volume":"272","author":"Sullivan","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2011.08.002_bib0315","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1172\/JCI2673","article-title":"Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2","volume":"102","author":"Sullivan","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.conb.2011.08.002_bib0320","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0891-5849(02)00803-1","article-title":"Apolipoprotein E isoform mediated regulation of nitric oxide release","volume":"32","author":"Brown","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.conb.2011.08.002_bib0325","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00016-7","article-title":"APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress","volume":"23","author":"Colton","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2011.08.002_bib0330_1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","article-title":"APOE genotype-specific differences in the innate immune response","volume":"30","author":"Vitek","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2011.08.002_bib0335","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/nbdi.1996.0023","article-title":"Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice","volume":"3","author":"Xu","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2011.08.002_bib0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0969-9961(02)00005-0","article-title":"Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice","volume":"12","author":"Ophir","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2011.08.002_bib0345","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.4049\/jimmunol.169.6.3370","article-title":"Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14","volume":"169","author":"Nadeau","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.conb.2011.08.002_bib0350","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1096\/fj.05-5423fje","article-title":"Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK","volume":"20","author":"Maezawa","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.conb.2011.08.002_bib0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-3-10","article-title":"Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice","volume":"3","author":"Maezawa","year":"2006","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.conb.2011.08.002_bib0360","article-title":"Gene expression profiles of RAW264.7 macrophages stimulated with preparations of LPS differing in isolation and purity","author":"Rutledge","year":"2011","journal-title":"Innate Immun"},{"key":"10.1016\/j.conb.2011.08.002_bib0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-3-21","article-title":"Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity","volume":"3","author":"Maezawa","year":"2006","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.conb.2011.08.002_bib0370","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2011.08.002_bib0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(96)01324-8","article-title":"Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro","volume":"749","author":"McGeer","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.conb.2011.08.002_bib0380","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0002-9440(10)62336-X","article-title":"Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity","volume":"166","author":"Shie","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.conb.2011.08.002_bib0385","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1096\/fj.10-176891","article-title":"Apolipoprotein E isoform-dependent microglia migration","volume":"25","author":"Cudaback","year":"2011","journal-title":"FASEB J"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438811001309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438811001309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:32:37Z","timestamp":1760704357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438811001309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0959438811001309"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2011.08.002","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2011.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}